Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Nov;72(5):1639–1649. doi: 10.1172/JCI111123

Identification and structural characterization of two incompletely processed forms of the fourth component of human complement.

A C Chan, J P Atkinson
PMCID: PMC370452  PMID: 6313766

Abstract

Immunoprecipitates of human C4 from EDTA-plasma were incubated with [14C]methylamine and analyzed by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and fluorography. In addition to finding label in the alpha-chains of the secreted (C4s) and predominant plasma (C4p) forms of C4, two additional molecules with apparent molecular weights of approximately 168,000 (p168) and approximately 125,000 (p125) covalently incorporated methylamine, indicating the presence of an internal thioester bond. These two molecules were present at a concentration of approximately 5% of total plasma C4 and were not immunoprecipitated by antisera to C3 or alpha 2-macroglobulin. A human hepatoma-derived cell line (HepG2), in addition to synthesizing C4s and small quantities of the polypeptide precursor of C4 (pro-C4), was found to secrete p168 and p125 at concentrations of 14 +/- 4.8 and 21 +/- 9.2% (mean +/- SD), respectively, of total secreted C4. These molecules were not found intracellularly. Both molecules were present on reduced, but not nonreduced, SDS-polyacrylamide gels. Chido (C4B) and Rodgers' (C4A) alloantisera precipitated the C4A and C4B variants of pro-C4, p168, p125, and C4s. Both tryptic and Staphylococcus aureus V8 protease peptide analyses showed homology between p168 and the beta- and alpha-chains and between p125 and the alpha- and gamma-chains. Partial NH2-terminal sequencing revealed that the beta-chain was NH2-terminal in p168 and that the alpha-chain was NH2-terminal in p125. Taken together, these data indicate that p168 and p125 represent uncleaved beta-alpha- and alpha-gamma-fragments of pro-C4, respectively. Thus, in most individuals, plasma C4 consists of five structurally distinct molecules, the single polypeptide precursor (pro-C4), the three-subunit secreted (C4s) and predominant plasma (C4p) forms of C4, and two incompletely processed two-subunit molecules with uncleaved beta-alpha- (p168) or uncleaved alpha-gamma (p125)-subunits. In addition, all five molecules are observed for both C4A (Rodgers) and C4B (Chido) structural genes.

Full text

PDF
1639

Images in this article

1641Image
on p.1641
1641Image
on p.1641
1642Image
on p.1642
1643Image
on p.1643
1643Image
on p.1643
1643Image
on p.1643
1644Image
on p.1644
1646Image
on p.1646

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awdeh Z. L., Alper C. A. Inherited structural polymorphism of the fourth component of human complement. Proc Natl Acad Sci U S A. 1980 Jun;77(6):3576–3580. doi: 10.1073/pnas.77.6.3576. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bokisch V. A., Dierich M. P., Mūller-Eberhard H. J. Third component of complement (C3): structural properties in relation to functions. Proc Natl Acad Sci U S A. 1975 Jun;72(6):1989–1993. doi: 10.1073/pnas.72.6.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bolotin C., Morris S., Tack B., Prahl J. Purification and structural analysis of the fourth component of human complement. Biochemistry. 1977 May 3;16(9):2008–2015. doi: 10.1021/bi00628a039. [DOI] [PubMed] [Google Scholar]
  4. Chan A. C., Mitchell K. R., Munns T. W., Karp D. R., Atkinson J. P. Identification and partial characterization of the secreted form of the fourth component of human complement: evidence that it is different from major plasma form. Proc Natl Acad Sci U S A. 1983 Jan;80(1):268–272. doi: 10.1073/pnas.80.1.268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Cleveland D. W., Fischer S. G., Kirschner M. W., Laemmli U. K. Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem. 1977 Feb 10;252(3):1102–1106. [PubMed] [Google Scholar]
  6. Gigli I. A single chain precursor of C4 in human serum. Nature. 1978 Apr 27;272(5656):836–837. doi: 10.1038/272836a0. [DOI] [PubMed] [Google Scholar]
  7. Gigli I., von Zabern I., Porter R. R. The isolation and structure of C4, the fourth component of human complement. Biochem J. 1977 Sep 1;165(3):439–446. doi: 10.1042/bj1650439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gordon J. I., Smith D. P., Andy R., Alpers D. H., Schonfeld G., Strauss A. W. The primary translation product of rat intestinal apolipoprotein A-I mRNA is an unusual preproprotein. J Biol Chem. 1982 Jan 25;257(2):971–978. [PubMed] [Google Scholar]
  9. Gorski J. P., Howard J. B. Effect of methylamine on the structure and function of the fourth component of human complement, C4. J Biol Chem. 1980 Nov 10;255(21):10025–10028. [PubMed] [Google Scholar]
  10. Graves C. B., Grabau G. G., Olson R. E., Munns T. W. Immunochemical isolation and electrophoretic characterization of precursor prothrombins in H-35 rat hepatoma cells. Biochemistry. 1980 Jan 22;19(2):266–272. doi: 10.1021/bi00543a003. [DOI] [PubMed] [Google Scholar]
  11. Hall R. E., Colten H. R. Cell-free synthesis of the fourth component of guinea pig complement (C4): identification of a precursor of serum C4 (pro-C4). Proc Natl Acad Sci U S A. 1977 Apr;74(4):1707–1710. doi: 10.1073/pnas.74.4.1707. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Harpel P. C. Studies on human plasma alpha 2-macroglobulin-enzyme interactions. Evidence for proteolytic modification of the subunit chain structure. J Exp Med. 1973 Sep 1;138(3):508–521. doi: 10.1084/jem.138.3.508. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Hugli T. E. Human anaphylatoxin (C3a) from the third component of complement. Primary structure. J Biol Chem. 1975 Nov 10;250(21):8293–8301. [PubMed] [Google Scholar]
  14. Janatova J., Tack B. F. Fourth component of human complement: studies of an amine-sensitive site comprised of a thiol component. Biochemistry. 1981 Apr 28;20(9):2394–2402. doi: 10.1021/bi00512a005. [DOI] [PubMed] [Google Scholar]
  15. Janatova J., Tack B. F., Prahl J. W. Third component of human complement: structural requirements for its function. Biochemistry. 1980 Sep 16;19(19):4479–4485. doi: 10.1021/bi00560a015. [DOI] [PubMed] [Google Scholar]
  16. Judd W. J., Kraemer K., Moulds J. J. The rapid identification of Chido and Rodgers antibodies using C4d-coated red blood cells. Transfusion. 1981 Mar-Apr;21(2):189–192. doi: 10.1046/j.1537-2995.1981.21281178155.x. [DOI] [PubMed] [Google Scholar]
  17. Karp D. R., Capra J. D., Atkinson J. P., Shreffler D. C. Structural and functional characterization of an incompletely processed form of murine C4 and Slp. J Immunol. 1982 May;128(5):2336–2341. [PubMed] [Google Scholar]
  18. Karp D. R., Parker K. L., Shreffler D. C., Capra J. D. Characterization of the murine C4 precursor (pro-C4): evidence that the carboxy-terminal subunit is the C4 gamma-chain. J Immunol. 1981 May;126(5):2060–2061. [PubMed] [Google Scholar]
  19. Karp D. R., Shreffler D. C., Atkinson J. P. Characterization of the Mr difference between secreted murine fourth component of complement and the major plasma form: evidence for carboxyl-terminal cleavage of the alpha chain. Proc Natl Acad Sci U S A. 1982 Nov;79(21):6666–6670. doi: 10.1073/pnas.79.21.6666. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Karp D. R., Shreffler D. C. S region genetic control of murine C4 biosynthesis: analysis of pro-C4 cleavage. Immunogenetics. 1982;16(2):171–176. doi: 10.1007/BF00364403. [DOI] [PubMed] [Google Scholar]
  21. Knowles B. B., Howe C. C., Aden D. P. Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980 Jul 25;209(4455):497–499. doi: 10.1126/science.6248960. [DOI] [PubMed] [Google Scholar]
  22. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  23. Laskey R. A., Mills A. D. Quantitative film detection of 3H and 14C in polyacrylamide gels by fluorography. Eur J Biochem. 1975 Aug 15;56(2):335–341. doi: 10.1111/j.1432-1033.1975.tb02238.x. [DOI] [PubMed] [Google Scholar]
  24. Law S. K., Lichtenberg N. A., Levine R. P. Covalent binding and hemolytic activity of complement proteins. Proc Natl Acad Sci U S A. 1980 Dec;77(12):7194–7198. doi: 10.1073/pnas.77.12.7194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Morris K. M., Aden D. P., Knowles B. B., Colten H. R. Complement biosynthesis by the human hepatoma-derived cell line HepG2. J Clin Invest. 1982 Oct;70(4):906–913. doi: 10.1172/JCI110687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Morris K. M., Goldberger G., Colten H. R., Aden D. P., Knowles B. B. Biosynthesis and processing of a human precursor complement protein, pro-C3, in a hepatoma-derived cell line. Science. 1982 Jan 22;215(4531):399–400. doi: 10.1126/science.7199205. [DOI] [PubMed] [Google Scholar]
  27. Nagata Y., Burger M. M. Wheat germ agglutinin. Molecular characteristics and specificity for sugar binding. J Biol Chem. 1974 May 25;249(10):3116–3122. [PubMed] [Google Scholar]
  28. Newell S. L., Shreffler D. C., Atkinson J. P. Biosynthesis of C4 by mouse peritoneal macrophages. I. Characterization of an in vitro culture system and comparison of C4 synthesis by "low" vs "high" C4 strains. J Immunol. 1982 Aug;129(2):653–659. [PubMed] [Google Scholar]
  29. O'Neill G. J., Yang S. Y., Dupont B. Two HLA-linked loci controlling the fourth component of human complement. Proc Natl Acad Sci U S A. 1978 Oct;75(10):5165–5169. doi: 10.1073/pnas.75.10.5165. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. O'Neill G. J., Yang S. Y., Tegoli J., Berger R., Dupont B. Chido and Rodgers blood groups are distinct antigenic components of human complement C4. Nature. 1978 Jun 22;273(5664):668–670. doi: 10.1038/273668a0. [DOI] [PubMed] [Google Scholar]
  31. Parker K. L., Roos M. H., Shreffler D. C. Structural characterization of the murine fourth component of complement and sex-limited protein and their precursors: evidence for two loci in the S region of the H-2 complex. Proc Natl Acad Sci U S A. 1979 Nov;76(11):5853–5857. doi: 10.1073/pnas.76.11.5853. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Parker K. L., Shreffler D. C., Capra J. D. Partial amino acid sequences of the murine fourth component of complement (C4): demonstration of homology with human C4 and identification of the amino-terminal subunit in pro-C4. Proc Natl Acad Sci U S A. 1980 Jul;77(7):4275–4278. doi: 10.1073/pnas.77.7.4275. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Roos M. H., Mollenhauer E., Démant P., Rittner C. A molecular basis for the two locus model of human complement component C4. Nature. 1982 Aug 26;298(5877):854–856. doi: 10.1038/298854a0. [DOI] [PubMed] [Google Scholar]
  34. Roos M. H., Shreffler D. C., Kornfeld S. Role of glycosylation in the proteolytic processing and secretion of the 4th component of complement (Ss protein) of the mouse. J Immunol. 1980 Oct;125(4):1869–1871. [PubMed] [Google Scholar]
  35. Rosa P. A., Shreffler D. C. Cultured hepatocytes from mouse strains expressing high and low levels of the fourth component of complement differ in rate of synthesis of the protein. Proc Natl Acad Sci U S A. 1983 Apr;80(8):2332–2336. doi: 10.1073/pnas.80.8.2332. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Rose S. M., Hansen T. H., Cullen S. E. Structural relation of murine "third locus" (H-2L) major histocompatibility antigens to the products of H-2K and H-2D loci. J Immunol. 1980 Nov;125(5):2044–2050. [PubMed] [Google Scholar]
  37. Schneider R. J., Atkinson J. P., Krause V., Kulczycki A., Jr Characterization of ligand-binding activity of isolated murine Fc gamma receptor. J Immunol. 1981 Feb;126(2):735–740. [PubMed] [Google Scholar]
  38. Schreiber R. D., Müller-Eberhard H. J. Fourth component of human complement: description of a three polypeptide chain structure. J Exp Med. 1974 Nov 1;140(5):1324–1335. doi: 10.1084/jem.140.5.1324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. Swenson R. P., Howard J. B. Characterization of alkylamine-sensitive site in alpha 2-macroglobulin. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4313–4316. doi: 10.1073/pnas.76.9.4313. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Swenson R. P., Howard J. B. Structural characterization of human alpha2-macroglobulin subunits. J Biol Chem. 1979 Jun 10;254(11):4452–4456. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES